Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield

Nosha Farhadfar, MD, Jack W. Hsu, MD, Brent R. Logan, PhD, Jennifer A. Sees, MPH, Pintip Chitphakdithai, PhD, Dennis L. Confer, MD, Michael A. Pulsipher, MD, Nirali N. Shah, MD, Galen E. Switzer, PhD, Bronwen E. Shaw, MD PhD, John R. Wingard, MD

Blood (2018) 132 (Supplement 1): 193.

https://doi.org/10.1182/blood-2018-193

Published: 2018

Journal Articles

Pain, Symptoms, AEs, and Recovery after Second Unrelated Donor Collection of Marrow/Peripheral Blood Stem Cells Are Similar to Those of the First Donation

David Stroncek, MD, Bronwen E. Shaw, MBChB, PhD MRCP, MRCPath, Brent Logan, PhD, Deidre Marie Kiefer, MPH, Pintip Chitphakdithai, PhD, Galen E. Switzer, PhD, Nirali N Shah, MD, John P. Miller, MD PhD, Dennis L. Confer, MD, Michael A Pulsipher, MD

Blood (2016) 128 (22): 2177.

https://doi.org/10.1182/blood.V128.22.2177.2177

Published: 2016

Journal Articles

Baseline Symptoms, Female Sex, and Younger Age Are Correlated with Higher Levels of Peri-Collection Pain, Symptoms, and Persistent Discomfort One Year after Related Donor BM and PBSC Donation: An Analysis of the Related Donor Safety Study (RDSafe)

Michael A. Pulsipher, MD, Brent R. Logan, PhD, Deidre M. Kiefer, MPH, Pintip Chitphakdithai, PhD, Galen E. Switzer, PhD, Marcie L Riches, MD MS, J. Douglas Rizzo, MD, Paolo Anderlini, MD, Susan F. Leitman, James W Varni, PhD, Amy Hays, MPH, RN, Hati Kobusingye, MS, RaeAnne M. Besser, John P. Miller, MD PhD, Rebecca J. Drexler, BS, Roberta J. King, MPH, Mary M. Horowitz, MD MS, Willis H. Navarro, MD, Dennis L. Confer, MD

Blood (2014) 124 (21): 3847.

https://doi.org/10.1182/blood.V124.21.3847.3847

Published: 2014

Journal Articles

Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Willis H. Navarro, John E. Levine, John P. Miller, Bronwen E. Shaw, Paul V. O’Donnell, Navneet S. Majhail, Dennis L. Confer

Blood (2014) 123 (23): 3655–3663.

https://doi.org/10.1182/blood-2013-12-542464

Published: 2014

Includes: Supplemental data

Journal Articles

Provider and Center Characteristics Of US Transplant Centers and Their Association With Survival After Allogeneic Hematopoietic Cell Transplantation (HCT) In Adults: Results From a National Survey Conducted By The Center For International Blood and Marrow Transplant Research (CIBMTR)

Navneet S. Majhail, MD, MS, Tammy Payton, BS, Lih-Wen Mau, PhD, MPH, Jennifer Le Rademacher, PhD, Pintip Chitphakdithai, PhD, Michael Eckrich, MD, Steven Joffe, MD, MPH, Stephanie J. Lee, MD, MPH, Charles F. LeMaistre, MD, Fausto R. Loberiza, Jr., MD, MS, Brent R. Logan, PhD, Elizabeth A Murphy, RN, ScD, Susan K. Parsons, MD, MRP, Ramona Repaczki-Jones, J. Douglas Rizzo, MD, Pam Robinett, Ellen Denzen, MS

Blood (2013) 122 (21): 1687.

https://doi.org/10.1182/blood.V122.21.1687.1687

Published: 2013

Journal Articles

Influence Of Race and Ethnicity On The Collection Of G-CSF Mobilized Peripheral Blood Stem Cells From Unrelated Donors, a Center For International Blood and Marrow Transplant Research Analysis

Jack W. Hsu, MD, John R. Wingard, MD, PhD, Brent R. Logan, PhD, Pintip Chitphakdithai, PhD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath, Steven C. Goldstein, MD, Paul V. O’Donnell, MD, PhD, FACP, Dennis L. Confer, MD

Blood (2013) 122 (21): 3273.

https://doi.org/10.1182/blood.V122.21.3273.3273

Published: 2013

Journal Articles

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program

Blood (2013) 121 (1): 197–206.

https://doi.org/10.1182/blood-2012-03-417667

Published: 2013

Includes: Supplemental data

Journal Articles

Significant and Rapid Improvement in Survival After Unrelated Donor (URD) Hematopoietic Cell Transplantation (HCT): Analysis of National Marrow Donor Program (NMDP) Facilitated Transplants From 2000 to 2009

Blood (2012) 120 (21): 234.

https://doi.org/10.1182/blood.V120.21.234.234

Published: 2012

Journal Articles

Peripheral Blood Stem Cell (PBSC) Donors Experience Higher Levels of Pain and Toxicities Early On, While Bone Marrow (BM) Donors Experience Slower Recovery and More Late Pain: A Prospective Study of the National Marrow Donor Program (NMDP).

Michael A. Pulsipher, MD, Pintip Chitphakdithai, PhD, Brent R. Logan, PhD, Steven C. Goldstein, MD, John E. Levine, MD, MS, Michael Lankiewicz, MD, David Stroncek, MD, Dennis L. Confer, MD

Blood (2010) 116 (21): 1107.

https://doi.org/10.1182/blood.V116.21.1107.1107

Published: 2010

Journal Articles

Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34 + cell dose

Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Susan F. Leitman, Paolo Anderlini, John P. Klein, Mary M. Horowitz, John P. Miller, Roberta J. King, Dennis L. Confer

Blood (2009) 114 (13): 2606–2616.

https://doi.org/10.1182/blood-2009-03-208355

Published: 2009

Includes: Supplemental data

Journal Articles

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

Michael A. Pulsipher, Pintip Chitphakdithai, John P. Miller, Brent R. Logan, Roberta J. King, J. Douglas Rizzo, Susan F. Leitman, Paolo Anderlini, Michael D. Haagenson, Seira Kurian, John P. Klein, Mary M. Horowitz, Dennis L. Confer

Blood (2009) 113 (15): 3604–3611.

https://doi.org/10.1182/blood-2008-08-175323

Published: 2009

Journal Articles

Volunteer Unrelated Donor PBSC Collection Efficacy and Recipient Outcomes: Results of a Prospective National Marrow Donor Program (NMDP) Trial, 1999–2003.

Michael Pulsipher, Pintip Chitphakdithai, John Klein, Seira Kurian, Susan Leitman, Paolo Anderlini, Brent Logan, Mary M. Horowitz, Dennis L. Confer

Blood (2006) 108 (11): 169.

https://doi.org/10.1182/blood.V108.11.169.169

Published: 2006

NARROW

Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield

Pain, Symptoms, AEs, and Recovery after Second Unrelated Donor Collection of Marrow/Peripheral Blood Stem Cells Are Similar to Those of the First Donation

Baseline Symptoms, Female Sex, and Younger Age Are Correlated with Higher Levels of Peri-Collection Pain, Symptoms, and Persistent Discomfort One Year after Related Donor BM and PBSC Donation: An Analysis of the Related Donor Safety Study (RDSafe)

Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

Provider and Center Characteristics Of US Transplant Centers and Their Association With Survival After Allogeneic Hematopoietic Cell Transplantation (HCT) In Adults: Results From a National Survey Conducted By The Center For International Blood and Marrow Transplant Research (CIBMTR)

Influence Of Race and Ethnicity On The Collection Of G-CSF Mobilized Peripheral Blood Stem Cells From Unrelated Donors, a Center For International Blood and Marrow Transplant Research Analysis

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program

Significant and Rapid Improvement in Survival After Unrelated Donor (URD) Hematopoietic Cell Transplantation (HCT): Analysis of National Marrow Donor Program (NMDP) Facilitated Transplants From 2000 to 2009

Peripheral Blood Stem Cell (PBSC) Donors Experience Higher Levels of Pain and Toxicities Early On, While Bone Marrow (BM) Donors Experience Slower Recovery and More Late Pain: A Prospective Study of the National Marrow Donor Program (NMDP).

Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34 + cell dose

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

Volunteer Unrelated Donor PBSC Collection Efficacy and Recipient Outcomes: Results of a Prospective National Marrow Donor Program (NMDP) Trial, 1999–2003.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only